ATE144534T1 - Antiherpes-pentapeptide - Google Patents

Antiherpes-pentapeptide

Info

Publication number
ATE144534T1
ATE144534T1 AT90112643T AT90112643T ATE144534T1 AT E144534 T1 ATE144534 T1 AT E144534T1 AT 90112643 T AT90112643 T AT 90112643T AT 90112643 T AT90112643 T AT 90112643T AT E144534 T1 ATE144534 T1 AT E144534T1
Authority
AT
Austria
Prior art keywords
tetrazolyl
carboxy
amino acid
antherpes
pentapeptides
Prior art date
Application number
AT90112643T
Other languages
English (en)
Inventor
Julian Adams
Pierre Louis Beaulieu
Pierre Lavallee
Raymond Plante
Sumanas Rakhit
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Application granted granted Critical
Publication of ATE144534T1 publication Critical patent/ATE144534T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT90112643T 1989-07-07 1990-07-03 Antiherpes-pentapeptide ATE144534T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000605092A CA1340684C (en) 1989-07-07 1989-07-07 Antiherpes pentapeptides

Publications (1)

Publication Number Publication Date
ATE144534T1 true ATE144534T1 (de) 1996-11-15

Family

ID=4140318

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90112643T ATE144534T1 (de) 1989-07-07 1990-07-03 Antiherpes-pentapeptide

Country Status (8)

Country Link
EP (1) EP0408973B1 (de)
JP (1) JP2877908B2 (de)
AT (1) ATE144534T1 (de)
AU (1) AU644085B2 (de)
CA (1) CA1340684C (de)
DE (1) DE69028953T2 (de)
IL (1) IL94979A (de)
NZ (1) NZ234374A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
ATE169931T1 (de) 1992-03-12 1998-09-15 Boehringer Ingelheim Ca Ltd Isosterische peptidderivate gegen herpes
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
AU2020353055B2 (en) 2019-09-26 2024-03-07 Gilead Sciences, Inc. Antiviral pyrazolopyridinone compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
EP0292255A3 (de) * 1987-05-22 1990-08-22 Merck & Co. Inc. Hemmungsstoff für Ribonukleotid-Reduktase

Also Published As

Publication number Publication date
AU644085B2 (en) 1993-12-02
DE69028953T2 (de) 1997-02-20
EP0408973A1 (de) 1991-01-23
DE69028953D1 (de) 1996-11-28
NZ234374A (en) 1997-06-24
AU5877890A (en) 1991-01-10
IL94979A (en) 1995-03-30
JPH03101696A (ja) 1991-04-26
JP2877908B2 (ja) 1999-04-05
IL94979A0 (en) 1991-06-10
CA1340684C (en) 1999-07-27
EP0408973B1 (de) 1996-10-23

Similar Documents

Publication Publication Date Title
DE69301897T2 (de) Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimitteln
ZA909744B (en) Amino alcohols
HU9301446D0 (en) Inhibitors or fetrovirus protease
NZ332255A (en) Use of herpes simplex virus glycoprotein d variants
ATE144534T1 (de) Antiherpes-pentapeptide
DE69015451D1 (de) Enzym-inhibierende Peptid-Derivate.
AU643448B2 (en) Antiviral peptides having a 2-Oxoalkyl amino acid side chain
DE69017113T2 (de) Pentapeptidderivate, wirksam gegen Herpes, die eine ersetzte Asparaginsäureseitenkette enthalten.
ATE70837T1 (de) Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
AU643403B2 (en) Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain
IE872692L (en) Oligopeptide antibiotics
ATE146183T1 (de) Verfahren zur herstellung von ribonukleotid- reduktasehemmern
EP0846682A4 (de) Penizillaminamid-derivate
ATE186737T1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden
DE69518252D1 (de) Verfahren zur herstellung von 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalin-derivaten
BR9604947A (pt) Genes que codificam polipept¡deos (lsirf) fatores reguladores de interferon linfoc¡tico
CA2019006A1 (en) Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
DE69711506T2 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE338057T1 (de) Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung
DE69116383T2 (de) Hexapeptidderivate von teicoplanin und verfahren zu deren herstellung
DE69514388D1 (de) Antiherpetische peptidomimetische verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties